Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

Published:2018-09 Issue:10152 Volume:392 Page:1036-1046
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gaziano J Michael,Brotons Carlos,Coppolecchia Rosa,Cricelli Claudio,Darius Harald,Gorelick Philip B,Howard George,Pearson Thomas A,Rothwell Peter M,Ruilope Luis Miguel,Tendera Michal,Tognoni Gianni

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force;Guirguis-Blake;Ann Intern Med,2016

2. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Lancet,2009

3. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

4. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement;Bibbins-Domingo;Ann Intern Med,2016

5. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

Cited by 638 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evidence base of the 10 most prescribed drugs in England, France, and the United States: a scoping review;Journal of Clinical Epidemiology;2024-10

2. Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention;Interventional Cardiology Clinics;2024-10

3. Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database;Frontiers in Pharmacology;2024-09-13

4. Prophylactic Effect of Aspirin and Other Medicine on Cerebral Infarction for Patients with Cardiovascular Diseases Risk Factors: A Systemic Review and Meta-Analysis;Cardiology in Review;2024-09-10

5. Agreement Between Mega-Trials and Smaller Trials;JAMA Network Open;2024-09-06